Journal
CEREBROVASCULAR DISEASES
Volume 34, Issue 2, Pages 95-105Publisher
KARGER
DOI: 10.1159/000341728
Keywords
Biomarkers; Cerebral reorganization; Immunology; Hypothermia; Reperfusion; Stem cell therapy; Stroke
Categories
Funding
- AstraZeneca
- GlaxoSmithKline
- Boehringer Ingelheim
- Lundbeck
- Novartis
- Janssen-Cilag
- Sanofi-Aventis
- Syngis
- Talecris
- German Research Council (D.F.G.)
- German Ministry of Education and Research (B.M.B.F.)
- European Union
- National Institutes of Health
- Heinz-Nixdorf Foundation
- Wellcome Trust [088414]
- Bertelsmann Foundation
Ask authors/readers for more resources
The European Stroke Organisation held its first European Stroke Science Workshop in Garmisch-Partenkirchen, Germany (December 15-17, 2011). Stroke experts based in Europe were invited to present and discuss their current research. The scope of the workshop was to review the most recent findings of selected topics in stroke, to exchange ideas, to stimulate new research, and to enhance collaboration between European stroke research groups. Seven scientific sessions were held, each starting with a keynote lecture to review the state of the art of the given topic, followed by 4 or 5 short presentations by experts. They were asked to limit their presentations to 10 slides containing only recent information. The meeting was organized by the executive committee of the European Stroke Organisation (Heinrich Mattle, chairman, Michael Brainin, Angel Chamorro, Werner Hacke, Didier Leys) and supported by the European Stroke Conference (Michael Hennerici). The following sections summarize the content of the workshop. Copyright (c) 2012 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available